mPEG-PLGA-NH2, MW x 2K, n 1K is a biodegradable, amphiphilic block copolymer composed of methoxy polyethylene glycol (mPEG) and poly(lactic-co-glycolic acid) (PLGA), featuring a terminal primary amine group. It combines the hydrophilic properties of mPEG with the biodegradable characteristics of PLGA to support nanoparticle formulation, controlled drug delivery, and biomaterials development. Additionally, its reactive amine group enables chemical functionalization and bioconjugation with suitable carboxyl-containing compounds and other amine-reactive molecules.
Key Features and Benefits
- Amphiphilic Block Copolymer: Combines hydrophilic mPEG and hydrophobic PLGA segments to support polymeric nanoparticle formation and self-assembly.
- Defined Molecular Weight Configuration: Features a nominal 2 kDa PLGA segment and 1 kDa mPEG segment, providing an approximate combined molecular weight of 3 kDa.
- Biodegradable PLGA Component: Contains hydrolytically degradable polyester linkages that support gradual polymer degradation under suitable experimental conditions.
- Hydrophilic mPEG Segment: Provides a hydrated polymer component that can improve colloidal stability while reducing nonspecific molecular interactions in appropriately designed formulations.
- Terminal Primary Amine Group: Offers reactive NH2 functionality for covalent coupling with activated carboxylic acids, NHS esters, and other compatible amine-reactive compounds.
- Nanoparticle Formation Capability: Specifically supports preparation of biodegradable polymeric nanoparticles using nanoprecipitation, emulsification, and solvent evaporation methods.
- Drug Encapsulation Potential: Enables investigation of hydrophobic drug encapsulation within PLGA-containing polymeric carriers.
- Controlled Release Properties: Supports development of delivery systems with adjustable release characteristics influenced by polymer composition, degradation, and formulation conditions.
- Surface Functionalization Versatility: Additionally, enables attachment of compatible peptides, targeting ligands, fluorescent labels, and other functional molecules through amine-mediated conjugation reactions.
Applications
- Polymeric Nanoparticle Formulation: Supports preparation of biodegradable nanoparticles for drug delivery and nanomedicine research.
- Controlled Drug Delivery: Enables development of polymer-based carriers for investigating sustained and degradation-dependent drug release.
- Hydrophobic Drug Encapsulation: Supports formulation studies involving poorly water-soluble compounds within PLGA-containing delivery systems.
- Targeted Drug Delivery Research: Provides reactive amine functionality for attaching suitable targeting ligands to polymeric carriers.
- Peptide and Biomolecule Conjugation: Specifically enables covalent attachment of compatible carboxyl-functionalized peptides and other biomolecules through amide bond formation.
- Polymeric Micelle Development: Supports investigation of amphiphilic polymer self-assembly and micellar structures under suitable formulation conditions.
- Nanoparticle Surface Modification: Furthermore, provides functional amine groups for introducing targeting, imaging, or analytical components onto polymeric nanoparticles.
- Biodegradable Biomaterials Research: Supports development of functionalized polymeric materials for tissue engineering and regenerative medicine research.
- Nanomedicine Research: Enables investigation of polymeric carrier stability, drug loading, release kinetics, and nanoparticle behavior in experimental systems.
Storage and Handling
- Storage: Store at −20°C in a dry, tightly sealed container, protected from moisture and heat. Additionally, minimize temperature fluctuations to reduce premature polymer degradation.
- Handling: Use clean, dry equipment and appropriate protective gear. Dissolve in compatible solvents, such as DMSO, DMF, acetone, or dichloromethane, after confirming solubility.
- Nanoparticle Preparation: Prepare nanoparticles using nanoprecipitation, emulsification, or solvent evaporation. Subsequently, optimize polymer concentration and processing conditions to achieve desired particle properties.
- Bioconjugation and Analysis: React terminal amine groups with suitable NHS esters, activated carboxylic acids, or other amine-reactive compounds. Furthermore, evaluate nanoparticle size, stability, drug loading, and polymer integrity using appropriate analytical methods.
mPEG-PLGA-NH2, MW x 2K, n 1K combines biodegradable PLGA, hydrophilic mPEG, and reactive primary amine functionality in a versatile polymer platform. Therefore, it supports nanoparticle development, controlled drug delivery, targeted bioconjugation, surface functionalization, and advanced biomaterials research.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.
